CD8A and neoplasm: While antigen-specific CD8+ T cells were maintained only at low frequencies in DC-immunized animals, immunization with HSCs resulted in an efficient maintenance of specific CTLs up to the time of tumor challenge at week 16 (Fig. 5A).